Learn more about Peter Attia’s digital program
Multiple problems with a study linking proximity to major roads to dementia, Parkinson’s disease, Alzheimer’s disease, and MS
“You miss 100% of the shots you don’t take.” —Wayne Gretzky
#124 – AMA #15: Real-world case studies—metabolic dysregulation, low testosterone, menopause, and more
As a follow up to AMA #14 where Peter explained his framework for analyzing labs, this “Ask Me Anything” (AMA)…
#159 – Peter Hotez, M.D., Ph.D.: Evolution of the anti-vaccine movement, the causes of autism, and COVID-19 vaccine state of affairs
“What started out as an anti-vaccine movement is now a movement against any kind of public health intervention and demonizing scientists and basically calling us the boogeyman.” —Peter Hotez
A hope for treating Alzheimer’s disease?
The FDA approves the first new medication for AD, aducanumab, in two decades
#272 ‒ Rapamycin: potential longevity benefits, surge in popularity, unanswered questions, and more | David Sabatini, M.D., Ph.D. and Matt Kaeberlein, Ph.D.
“[Rapamycin] is the most robust and reproducible drug that we know about today for impacting not only longevity, but to the extent that we can measure various metrics of healthspan in complex animals, rapamycin also seems to positively impact pretty much every aspect of health span that we measure.” —Matt Kaeberlein
#281 ‒ Longevity drugs, aging biomarkers, and updated findings from the Interventions Testing Program (ITP) | Rich Miller, M.D., Ph.D.
“What we try to do is quite simple. We try to find drugs that will slow aging and extend mouse lifespan.” —Rich Miller
#26 – AMA #3: supplements, women’s health, patient care, and more
“In case you haven’t guessed yet, there’s been a lot of drug traffic on the beach. And I’m not talking about Robitussin and No-Doze. I’m talking about the hard stuff, and a lot of it. I’ve been trying to find out who’s behind it. It hasn’t been easy. I don’t shower much.” —Irwin M. Fletcher
Qualy #24 – What are the “ABCs” of Alzheimer’s prevention?
Today’s episode of The Qualys is from podcast #18 – Richard Isaacson, M.D.: Alzheimer’s prevention.
Can an annual flu vaccine reduce your risk of Alzheimer’s disease?
A recent retrospective study suggests that flu vaccines reduce risk of Alzheimer’s disease, but the study raises as many questions as it answers.
AMA, Alzheimer’s, podcast rec, and NAD rec
Spoiler alert: Not sure taking NAD precursors orally is doing much beyond enriching the companies that make them.